These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 10428073

  • 1. The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
    Merino M, Vizuete ML, Cano J, Machado A.
    J Neurochem; 1999 Aug; 73(2):750-7. PubMed ID: 10428073
    [Abstract] [Full Text] [Related]

  • 2. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
    Prehn JH, Lippert K, Krieglstein J.
    Eur J Pharmacol; 1995 Jan 13; 292(2):179-89. PubMed ID: 7720791
    [Abstract] [Full Text] [Related]

  • 3. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors.
    Vidal L, Durán R, Faro LF, Campos F, Cervantes RC, Alfonso M.
    Toxicology; 2007 Sep 05; 238(2-3):140-6. PubMed ID: 17624650
    [Abstract] [Full Text] [Related]

  • 4. Role of glutamate receptors and nitric oxide on the effects of glufosinate ammonium, an organophosphate pesticide, on in vivo dopamine release in rat striatum.
    Faro LR, Ferreira Nunes BV, Alfonso M, Ferreira VM, Durán R.
    Toxicology; 2013 Sep 15; 311(3):154-61. PubMed ID: 23810826
    [Abstract] [Full Text] [Related]

  • 5. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.
    Kohara A, Okada M, Tsutsumi R, Ohno K, Takahashi M, Shimizu-Sasamata M, Shishikura J, Inami H, Sakamoto S, Yamaguchi T.
    J Pharm Pharmacol; 1998 Jul 15; 50(7):795-801. PubMed ID: 9720630
    [Abstract] [Full Text] [Related]

  • 6. Effects of glutamate receptor agonists and antagonists on Ca2+ uptake in rat hippocampal slices lesioned by glucose deprivation or by kainate.
    Alici K, Gloveli T, Schmitz D, Heinemann U.
    Neuroscience; 1997 Mar 15; 77(1):97-109. PubMed ID: 9044378
    [Abstract] [Full Text] [Related]

  • 7. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.
    Campos F, Alfonso M, Vidal L, Faro LR, Durán R.
    Eur J Pharmacol; 2006 Oct 24; 548(1-3):90-8. PubMed ID: 16963020
    [Abstract] [Full Text] [Related]

  • 8. Local infusion of the (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block D1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum.
    Keefe KA, Gerfen CR.
    Neuroscience; 1999 Mar 24; 89(2):491-504. PubMed ID: 10077330
    [Abstract] [Full Text] [Related]

  • 9. Crucial role of kainate receptors in mediating striatal kainate injection-induced decrease in acetylcholine M(1) receptor binding in rat forebrain.
    Jin S, Yang J, Lee WL, Wong PT.
    Brain Res; 2000 Nov 03; 882(1-2):128-38. PubMed ID: 11056192
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
    Wang LG, Zeng J, Yuan WJ, Su DF, Wang WZ.
    Exp Physiol; 2007 Sep 03; 92(5):849-58. PubMed ID: 17573415
    [Abstract] [Full Text] [Related]

  • 11. AMPA- and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices.
    Jin S.
    Neuropharmacology; 1997 Sep 03; 36(11-12):1503-10. PubMed ID: 9517420
    [Abstract] [Full Text] [Related]

  • 12. Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons.
    Di Loreto S, Florio T, Scarnati E.
    Exp Brain Res; 1992 Sep 03; 89(1):79-86. PubMed ID: 1351000
    [Abstract] [Full Text] [Related]

  • 13. Effects of N-methyl-D-aspartate, kainate or veratridine on extracellular concentrations of free D-serine and L-glutamate in rat striatum: an in vivo microdialysis study.
    Hashimoto A, Kanda J, Oka T.
    Brain Res Bull; 2000 Oct 03; 53(3):347-51. PubMed ID: 11113591
    [Abstract] [Full Text] [Related]

  • 14. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM, Nomikos GG, Schilström B, Svensson TH.
    J Neurosci Res; 1998 Mar 01; 51(5):583-92. PubMed ID: 9512002
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
    Kenny PJ, Gasparini F, Markou A.
    J Pharmacol Exp Ther; 2003 Sep 01; 306(3):1068-76. PubMed ID: 12805481
    [Abstract] [Full Text] [Related]

  • 17. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.
    Mazarati AM, Wasterlain CG.
    Neurosci Lett; 1999 Apr 23; 265(3):187-90. PubMed ID: 10327162
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA, Wüllner U, Heneka MT, Schulz JB, Kunow M, Wachtel H, Klockgether T.
    Synapse; 1997 Aug 23; 26(4):381-91. PubMed ID: 9215597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.